Krones intends to expand its portfolio into injection molding with the imminent acquisition of Netstal
|
EQS-News: Krones AG
/ Key word(s): Miscellaneous
Corporate News Release 29 January 2024 Krones intends to expand its portfolio into injection molding with the imminent acquisition of Netstal Krones is close to sign an agreement regarding the acquisition of 100% of Netstal Maschinen AG (Netstal) from KraussMaffei. Based in Naefels, Switzerland, Netstal is a leading supplier of injection molding machines to the beverage market (PET preforms and caps) as well as to the medical and thin-wall packaging market. The company is a technological leader in its markets and has already been a strategic partner of Krones in the past. In the 2023 fiscal year, Netstal generated with a workforce of more than 500 employees revenue of more than EUR 200 million. The profitability of the company is currently below the Krones Group level but is expected to close this gap over the coming years. Netstal will be reported as part of the segment Filling and Packaging Technology. Krones finances the purchase with existing liquid funds, but also may take advantage of partial debt financing. The acquisition of Netstal is benefitting Krones on various dimensions. Netstal’s PET and Cap businesses complement Krones’ product portfolio for the beverage market. With respect to PET closed-loop solutions Krones then covers all technologies required from injection molding to PET container production through to filling/packaging and recycling. The medical and thin-wall packaging segments of Netstal support the Krones strategy to diversify into the medical/pharma market as well as into food and home-personal-care applications. Netstal will retain its business responsibility within Krones, while benefitting from the international set-up and scale of Krones. The final signing of the transaction is scheduled for beginning of February 2024. With the acquisition of Netstal, Krones continues to succesfully implement its M&A strategy. After signing the transaction is subject to approval under the relevant antitrust legislation. Krones expects the transaction to be completed within the first half of 2024.
Contact:
29.01.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Krones AG |
| Böhmerwaldstraße 5 | |
| 93073 Neutraubling | |
| Germany | |
| Phone: | +49 (0)9401 701169 |
| Fax: | +49 (0)9401 709 1 1169 |
| E-mail: | investor-relations@krones.com |
| Internet: | www.krones.com |
| ISIN: | DE0006335003 |
| WKN: | 633500 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1824529 |
| End of News | EQS News Service |
|
|
1824529 29.01.2024 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.